跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
EVEROLIMUS BIOCON 2,5 MG COMPRIMIDOS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
EVEROLIMUS BIOCON 2,5 MG COMPRIMIDOS EFG
Approved
STANDARD
EVEROLIMUS BIOCON 2,5 MG COMPRIMIDOS EFG
Biocon Pharma Malta I Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 3, 2022
Approval ID
78b12fed8b17a5b8
Company
Biocon Pharma Malta I Limited
Type
Standard
Approval Details
Approval Id
78b12fed8b17a5b8
Drug Cima Aemps Name
EVEROLIMUS BIOCON 2,5 MG COMPRIMIDOS EFG
Register Number
86609
Holder Company Name
Biocon Pharma Malta I Limited
Marketing Company Name
Biocon Pharma Malta I Limited
Authorization Date
2022-03-03
Dosage Form
COMPRIMIDO
Dose
2,5 mg
Route Of Administration
VÍA ORAL
Prescription Type
Diagnóstico Hospitalario
Commercialized
No
Company Name
Biocon Pharma Malta I Limited
Active Ingredients
EVEROLIMUS
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 3, 2022
Approval ID
78b12fed8b17a5b8
Type
Standard
Back to CIMA-AEMPS Approvals